03:48 AM EDT, 05/23/2025 (MT Newswires) -- Sinovac Biotech (SVA) said late Thursday it received a notification from Nasdaq informing the Chinese biopharmaceutical company of non-compliance with a listing rule related to the delayed filing of its 2024 annual report.

The company has until July 15 to submit a plan to regain compliance. If Nasdaq accepts the plan, Sinovac could be granted an extension until Nov. 11 to regain compliance.

The company's audit committee is "actively searching" for a new auditor following the previously disclosed resignation of Grant Thornton Zhitong Certified Public Accountants.